Olema Pharmaceuticals, Inc. (OLMA)

24.15 -0.54 (-2.19%) USD  |  NASDAQ  |  Feb 25, 15:48
More

Olema Pharmaceuticals Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for OLMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Cidara Therapeutics, Inc. --
Cogent Biosciences, Inc. --
Corvus Pharmaceuticals, Inc. --
BridgeBio Pharma, Inc. Upgrade
Oric Pharmaceuticals, Inc. --